| Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the Detection of Prostate Cancer Recurrence in the Setting of Biochemical Failure Following Radical Prostatectomy (NCT06907641) | St Vincent's Hospital, Sydney | 2024-11-21 |
| A Study of HRS-4642 Monotherapy or in Combination With Adebrelimab in the Treatment of Advanced Biliary Tract Tumors. (NCT06620848) | Shanghai Zhongshan Hospital | 2024-11-21 |
| A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus (NCT06628362) | Carmot Therapeutics, Inc. | 2024-11-21 |
| Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer (NCT06693128) | Ruijin Hospital | 2024-11-21 |
| A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer (NCT06678659) | Recursion Pharmaceuticals Inc. | 2024-11-21 |
| A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD) (NCT06619561) | Deciphera Pharmaceuticals, LLC | 2024-11-21 |
| A Clinical Trial Evaluating TQB2102 for Injection in Combination With Behmosubaisumab/Payamprolizumab With or Without Chemotherapy in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma (NCT06767800) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2024-11-21 |
| Effect Camostat for Kidney Protection in Chronic Kidney Disease (NCT06794593) | Odense University Hospital | 2024-11-21 |
| The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease (NCT06528405) | National Taiwan University Hospital | 2024-11-21 |
| Timing of TAP Blocks in Bariatric Surgery (NCT06270147) | McMaster University | 2024-11-21 |
| Integrated Traditional Chinese Medicine Day Care Program for Metabolic Syndrome (NCT06703788) | Chang Gung Memorial Hospital | 2024-11-20 |
| The Treatment of Sepsis Induced Myocardial Dysfunction With Yiqilishui Formula (NCT06686355) | Dongzhimen Hospital, Beijing | 2024-11-20 |
| Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy (NCT06510361) | Beth Israel Deaconess Medical Center | 2024-11-20 |
| Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke (NCT06587347) | Capital Medical University | 2024-11-20 |
| COVID-19 Booster and IIV Schedule in Immunocompromised Hosts (NCT06599658) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2024-11-20 |
| Liposomal Irinotecan Combined with Sintilimab for Second-line Treatment of Progressive Gastric Cancer (NCT06697366) | Ruijin Hospital | 2024-11-20 |
| GIST Oral Paclitaxel(Liporaxel) (NCT06326346) | Asan Medical Center | 2024-11-20 |
| Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines (NCT06137664) | PATH | 2024-11-20 |
| Tislelizumab Combined with Chemotherapy and All Trans Retinoic Acid for Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma (NCT06703047) | Fudan University | 2024-11-20 |
| Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma (NCT07602049) | Sun Yat-sen University | 2024-11-20 |
| Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma (NCT07254754) | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | 2024-11-20 |
| Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC (NCT06714708) | Anhui Provincial Cancer Hospital | 2024-11-20 |
| A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma (NCT06683885) | Mingzhi Zhang | 2024-11-20 |
| SGLT2 Adjunct in T1D (NCT07591077) | Ain Shams University | 2024-11-20 |
| ARX788 in HER2-positive Metastatic Breast Cancer Patients (NCT06663748) | Henan Cancer Hospital | 2024-11-20 |
| Immunobridging/Maintenance Therapy Versus Non-bridging Therapy in CAR-T Therapy for Low-risk R/R B-NHL (NCT06695013) | Ruijin Hospital | 2024-11-20 |
| Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection (NCT06456424) | University of Calgary | 2024-11-20 |
| Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer (NCT06659042) | Shanghai Chest Hospital | 2024-11-20 |
| CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. (NCT06690775) | TORL Biotherapeutics, LLC | 2024-11-20 |
| Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1 (NCT06532656) | Gilead Sciences | 2024-11-20 |
| Ivonescimab in the Treatment of Multiple Advanced Tumors (NCT06683846) | Fudan University | 2024-11-20 |
| NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (NCT06622668) | Intellia Therapeutics | 2024-11-20 |
| Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) (NCT06589440) | Stingray Therapeutics | 2024-11-20 |
| A Study Assessing KB304 for the Treatment of Wrinkles in Women (NCT06724900) | Krystal Biotech, Inc. | 2024-11-20 |
| Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma (NCT06730308) | Sun Yat-sen University | 2024-11-20 |
| Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery (NCT06888063) | Erasmus Medical Center | 2024-11-20 |
| Second-line Irinotecan Liposome Combination Regimen for Irinotecan-treated Pancreatic Cancer (NCT06700603) | Rui-hua Xu, MD, PhD | 2024-11-20 |
| Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP (NCT06686927) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-11-20 |
| Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer (NCT06631092) | NEC Bio B.V | 2024-11-20 |
| Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects (NCT06671821) | Shandong Suncadia Medicine Co., Ltd. | 2024-11-20 |
| A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer (NCT06369285) | Puma Biotechnology, Inc. | 2024-11-19 |
| The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy (NCT06388720) | National Cancer Center, Korea | 2024-11-19 |
| Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older (NCT06695117) | Sanofi | 2024-11-19 |
| Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial) (NCT06116682) | SWOG Cancer Research Network | 2024-11-19 |
| An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR/ALK/ROS1-negative Advanced NSCLC in the Second-line Setting (NCT06749886) | Shanghai Pulmonary Hospital, Shanghai, China | 2024-11-19 |
| Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors (NCT06727617) | Tianjin Medical University Cancer Institute and Hospital | 2024-11-19 |
| DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations (NCT06988475) | Cancer Research UK | 2024-11-19 |
| Allo HSCT for High Risk Hemoglobinopathies (NCT06872333) | Masonic Cancer Center, University of Minnesota | 2024-11-19 |
| Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion (NCT06439485) | M.D. Anderson Cancer Center | 2024-11-19 |
| Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma (NCT06569680) | Izidore Lossos, MD | 2024-11-19 |
| A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age (NCT06702449) | GlaxoSmithKline | 2024-11-19 |
| Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue (NCT06740526) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2024-11-19 |
| A Study to See How Well and How Safely Different Treatments Work in a Group of Participants With Non-Small Cell Lung Cancer (NSCLC) (NCT06624059) | Hoffmann-La Roche | 2024-11-18 |
| Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia (NCT07514936) | Chinese PLA General Hospital | 2024-11-18 |
| A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC) (NCT06465329) | Regeneron Pharmaceuticals | 2024-11-18 |
| CAR T-cell Therapy in Patients With Renal Dysfunction (NCT05909059) | Northside Hospital, Inc. | 2024-11-18 |
| Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate. (NCT06705023) | Ralf Rothoerl | 2024-11-18 |
| Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older (NCT06695130) | Sanofi | 2024-11-18 |
| Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer (NCT06228053) | Syntrix Biosystems, Inc. | 2024-11-18 |
| Intracochlear Application of VSF1.01 for the Reduction of Cochlear Implant Surgery Related Trauma (NCT06545175) | Hannover Medical School | 2024-11-18 |
| Study of Psilocybin for Anorexia in Young Adults (NCT06399263) | Marissa Raymond-Flesch, MD, MPH | 2024-11-18 |
| Dusquetide for the Treatment of Behcet's Disease (NCT06386744) | Soligenix | 2024-11-18 |
| An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer (NCT06693336) | ToLymph Inc. | 2024-11-18 |
| A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL (NCT06484920) | Rita Assi | 2024-11-18 |
| Lateral Cord Magnetic Stimulation For Refractory Spastic Cerebral Palsy (NCT03676439) | Sociedad Argenttina de Neuromodulación | 2024-11-18 |
| Botensilimab and Balstilimab Optimization in Colorectal Cancer (NCT06268015) | Nicholas DeVito, MD | 2024-11-18 |
| Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in ER-positive Breast Cancer (NCT06695039) | Asan Medical Center | 2024-11-18 |
| To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension (NCT06343298) | E-Star BioTech, LLC | 2024-11-17 |
| MMRC Horizon One: RRMM (MMRC-099) (NCT06171685) | Multiple Myeloma Research Consortium | 2024-11-17 |
| Pivotal BE Study of TAH3311 ODF vs ELIQUIS® Tablet Under Fasted Condition in Healthy Volunteers (NCT06689436) | TAHO Pharmaceuticals Ltd. | 2024-11-16 |
| Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma (NCT06664021) | Anhui Provincial Hospital | 2024-11-16 |
| AK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients (NCT06489197) | Tianjin Medical University Cancer Institute and Hospital | 2024-11-16 |
| Canagliflozin Targeting Vascular Inflammation (NCT05427084) | Ottawa Heart Institute Research Corporation | 2024-11-15 |
| MDMA-Assisted CBCT for PTSD vs CBCT RCT (NCT06044675) | Remedy | 2024-11-15 |
| Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer (NCT06722911) | Zhejiang Provincial People's Hospital | 2024-11-15 |
| Lorlatinib as Neoadjuvant Treatment in Stage IB-IIIB ALK-rearranged Non-Small Cell Lung Cancer (NCT06682884) | Peking University People's Hospital | 2024-11-15 |
| Inflammation REduction to Prevent cArdiovascular Injury in Renal Disease (REPAIR) (NCT06203977) | Hamilton Health Sciences Corporation | 2024-11-15 |
| CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma (NCT06641453) | Chinese PLA General Hospital | 2024-11-15 |
| Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis (NCT06873100) | Peking University People's Hospital | 2024-11-15 |
| Immediate Release Torsemide Versus Extended Release Torsemide After Salty Meal (NCT06176794) | Sarfez Pharmaceuticals, Inc. | 2024-11-15 |
| Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction (NCT06576921) | Xijing Hospital | 2024-11-15 |
| Donafenib Combined With Capecitabine for Postoperative Adjuvant Therapy of Biliary Malignant Tumors With High-risk Recurrence Risk (NCT06685289) | The First Affiliated Hospital with Nanjing Medical University | 2024-11-15 |
| Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML (NCT06158828) | Washington University School of Medicine | 2024-11-15 |
| Vsling™ I: Clinical Evaluation of the Vsling™ Device for Ventricular Repair in Patients With Heart Failure (NCT06851949) | Cardiac Success | 2024-11-15 |
| Tolerance and Effectiveness of C14 on HPV Infection (NCT06672653) | MGB Pharma | 2024-11-15 |
| A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial) (NCT06422884) | Endeavor Biomedicines, Inc. | 2024-11-15 |
| LaCE (Lactobacillus Paracasei LPB27 On Early Childhood Eczema) (NCT06584552) | The University of New South Wales | 2024-11-15 |
| A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1 (NCT06698003) | Memorial Sloan Kettering Cancer Center | 2024-11-15 |
| A Trial to Evaluate the Efficacy and Safety of Methoxyethyl Etomidate Hydrochloride in Gastroscopy/Colonoscopy (NCT06682546) | Ahon Pharmaceutical Co., Ltd. | 2024-11-15 |
| REVERSE: Improving Treatment-resistant Post Traumatic Stress Disorder (PTSD) with Glucocorticoid Receptor (GR) Antagonism (NCT06689254) | Christiaan Vinkers | 2024-11-15 |
| Evaluating a Nitric Oxide Generator, Nebivolol as a Disease Modifier in Patients With Diabetic Neuropathy. (NCT06201611) | St. John's Research Institute | 2024-11-15 |
| Role of Oral Voriconazole in the Treatment of Resistant Dermatophyte Infections (NCT06680544) | Sheikh Zayed Medical College | 2024-11-15 |
| Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence (NCT06682728) | University of California, Irvine | 2024-11-15 |
| Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer (NCT06572813) | First Affiliated Hospital of Zhejiang University | 2024-11-15 |
| Bupivacaine and Epinephrine Injection Study (NCT06456255) | Amin Javer | 2024-11-15 |
| A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy (NCT06654440) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2024-11-15 |
| Carvedilol and Alverine in Portal Hypertension (NCT06696248) | Shanghai Changzheng Hospital | 2024-11-15 |
| 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours (NCT06630260) | Institute of Cancer Research, United Kingdom | 2024-11-15 |
| Different Cycles of Preoperative Neoadjuvant Sintilimab in Mismatch-repair Deficient/microsatellite Instability-high, Locally Advanced Colorectal Cancer (NCT06698757) | Yugui Lian | 2024-11-15 |
| Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer (NCT06660407) | Mayo Clinic | 2024-11-14 |